Capstone Investment Advisors
EBS icon

Capstone Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Capstone Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,840
Closed -$57.5K – 1628
2025
Q1 		$57.5K Buy
+11,840
New +$98K ﹤0.01% 1292
2017
Q2 		– Sell
-8,247
Closed -$239K – 706
2017
Q1 		$239K Buy
+8,247
New +$251K 0.01% 755
2016
Q3 		– Sell
-19,019
Closed -$534K – 781
2016
Q2 		$534K Buy
19,019
+11,019
+138% +$432K 0.01% 466
2016
Q1 		$290K Buy
+8,000
New +$283K 0.01% 531

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Capstone Investment Advisors's EBS Position: Q2 2025 in Review

Capstone Investment Advisors sold out of Emergent Biosolutions (EBS) in Q2 2025, closing a stake of 11,840 shares — an estimated $57.5K sold.

Capstone Investment Advisors first reported a position in EBS in Q1 2016 and held it in 4 quarters. The position peaked at $534K in Q2 2016. 161 funds tracked by Wall St. Rank hold EBS as of Q2 2025.

  • Capstone Investment Advisors reported no remaining Emergent Biosolutions position as of Q2 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 11,840 Emergent Biosolutions shares in Q2 2025, an estimated $57.5K.
  • Capstone Investment Advisors first reported a position in Emergent Biosolutions in Q1 2016 and held it in 4 quarters.
  • Capstone Investment Advisors's Emergent Biosolutions position peaked at $534K in Q2 2016.
  • 161 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2025.

Based on Capstone Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.